Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 21, 2026
Reporting period
Not applicable
Filed with the SEC
Jan 23, 2026
CFOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-021249
Filed / recorded
Jan 23, 2026, 10:05 PM UTC
Added to OQRO
Oct 6, 2026, 7:37 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
GLOBUS MEDICAL INC
Issuer CIK
1237831
Ticker
GMED
Reporting person
Kyle Kline
Relationship
Officer
Officer title
Senior Vice President, CFO
Security
Stock Option (Right to Buy Class A Common Stock)
Table
Derivative (Table II)
Transaction date
Jan 21, 2026
Transaction code
A
Shares / units
30,000
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
30,000
Ownership form
Direct
Amendment
No
Footnotes from the filing
These options were granted on January 21, 2026, and vest over a four-year period with 1/4 of the options vesting on January 1, 2027, and then 1/48 of the options vesting each month thereafter.